뉴젠아이브이에프 (NIVF) 주가

뉴젠아이브이에프(NIVF)는 NASDAQ에 상장된 Healthcare · Medical Care Facilities 기업입니다. 현재가 $0.59 (+6.51%), 시가총액 $0.00B, PER 0.02, 52주 범위 $0.30 ~ $3.70.

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IV

핵심 지표

• 현재가: $0.59 (+6.51%)
• 시가총액: $0.00B
• PER (주가수익비율): 0.02
• 52주 최저~최고: $0.30 ~ $3.70
• 섹터: Healthcare
• 산업: Medical Care Facilities
• 거래소: NASDAQ

뉴젠아이브이에프의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

뉴젠아이브이에프 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.03
• 순이익률: 2.09%
• 영업이익률: -3.49%

자주 묻는 질문